Kang'an Cheng

Kang'an Cheng


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
XLXiaole Liu
Xiaole Liu
DKDehui Kong
Dehui Kong
YLYanbo Liu
Yanbo Liu
JFJia Fu
Jia Fu
PGPeng Gao
Peng Gao
ZFZhongjie Fan
Zhongjie Fan

24 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
FZFan Zhang
Fan Zhang
DYDeyan Yang
Deyan Yang
JLJing Li
Jing Li
PGPeng Gao
Peng Gao
TCTaibo Chen
Taibo Chen
LHLiqun He
Liqun He
Background: Since December 2019, a cluster of coronavirus disease 2019 (COVID-19) occurred in Wuhan, Hubei Province, China and spread rapidly from China to other countries. In-hospital mortality are high in severe cases and cardiac injury characterized by elevated cardiac troponin are common among them. The mechanism of cardiac injury and the relationship between cardiac injury and in-hospital mortality remained unclear. Studies focused on cardiac injury in COVID-19 patients are scarce. Objectives: To investigate the association between cardiac injury and in-hospital mortality of patients with confirmed or suspected COVID-19. Methods: Demographic, clinical, treatment, and laboratory data of consecutive confirmed or suspected COVID-19 patients admitted in Wuhan No.1 Hospital from 25 th December, 2019 to 15 th February, 2020 were extracted from electronic medical records and were retrospectively reviewed and analyzed. Univariate and multivariate Cox regression analysis were used to explore the risk factors associated with in-hospital death. Results: A total of 110 patients with confirmed (n=80) or suspected (n=30) COVID-19 were screened and 48 patients (female 31.3%, mean age 70.58±13.38 year old) among them with high-sensitivity cardiac troponin I (hs-cTnI) test within 48 hours after admission were included, of whom 17 (17/48, 35.4%) died in hospital while 31 (31/48, 64.6%) were discharged or transferred to other hospital. High-sensitivity cardiac troponin I was elevated in 13 (13/48, 27.1%) patents. Multivariate Cox regression analysis showed pulse oximetry of oxygen saturation (SpO 2 ) on admission (HR 0.704, 95% CI 0.546-0.909, per 1% decrease, p=0.007), elevated hs-cTnI (HR 10.902, 95% 1.279-92.927, p=0.029) and elevated d-dimer (HR 1.103, 95%CI 1.034-1.176, per 1mg/L increase, p=0.003) on admission were independently associated with in-hospital mortality. Conclusions: Cardiac injury defined by hs-cTnI elevation and elevated d-dimer on admission were risk factors for in-hospital death, while higher SpO 2 could be seen as a protective factor, which could help clinicians to identify patients with adverse outcome at the early stage of COVID-19.

26 July 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
ZCZhongwei Cheng
Zhongwei Cheng
HDHua Deng
Hua Deng
KCKang'an Cheng
Kang'an Cheng
TCTaibo Chen
Taibo Chen
PGPeng Gao
Peng Gao
QFQuan Fang
Quan Fang

30 March 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
XLXiaole Liu
Xiaole Liu
DKDehui Kong
Dehui Kong
HLHui Lian
Hui Lian
XZXiaoyi Zhao
Xiaoyi Zhao
YZYakun Zhao
Yakun Zhao
ZFZhongjie Fan
Zhongjie Fan
Objectives The purpose of this study is to analyse hospital charges for patients with haemorrhagic stroke in China and investigate potential factors associated with inpatient charges. Methods The study participants were in-hospital patients with a primary diagnosis of haemorrhagic stroke from all the secondary and tertiary hospitals in Beijing during the period from 1 March 2012 to 28 February 2015. Distribution characteristics of detailed hospital charges were analysed. The influence of potential factors on hospital charges was researched using a stepwise multiple regression model. Results A total of 34 890 patients with haemorrhagic stroke of mean age 61.19±14.37 years were included in the study, of which 37.2% were female. Median length of hospital stay (LOHS) was 15 days (IQR 9–23) and median hospital cost was 18 577 Chinese yuan (CNY) (IQR 10 442–39 784). The hospital costs for patients in Western medicine hospitals (median 19 651 CNY) were significantly higher (P<0.01) than those in traditional Chinese medicine hospitals (median 14 560 CNY), and were significantly higher (P<0.01) for Level 3 hospitals (median 20 029 CNY) than for Level 2 hospitals (median 16 095 CNY). The proportion of medicine fees and bed fees within total hospital charges showed a decreasing trend during the study period. With stepwise multiple regression, the major factors associated with hospital charges were LOHS, surgery, pulmonary infection, ventilator usage, hospital level, occupation, hyperlipidaemia, hospital type, in-hospital death, sex and age. Conclusion We conclude that medicines form the largest part of hospital charges but are showing a decreasing trend, and LOHS is strongly associated with patient charges for haemorrhagic stroke in China. This implies that the cost structure is very unreasonable in China and medical technology costs fail to be fully manifested. A reasonable decrease in medicine charges and shortening LOHS may be effective ways to reduce hospital charges.

11 January 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
JYJiaqi Yu
Jiaqi Yu
FKFanyi Kong
Fanyi Kong
PGPeng Gao
Peng Gao
TCTaibo Chen
Taibo Chen
YLYongtai Liu
Yongtai Liu
KCKang'an Cheng
Kang'an Cheng
Introduction: Amyloid light-chain cardiac amyloidosis is a progressive infiltrative disease characterized by the deposition of amyloid fibrils in the cardiac tissue, which can cause serious atrioventricular block requiring pacemaker implantation. Left bundle branch pacing has emerged as an alternative method for delivering physiological pacing to achieve electrical synchrony of the left ventricle. However, left bundle branch pacing in patients with amyloid light-chain cardiac amyloidosis has not been studied in detail. Therefore, in this study, we present a case of left bundle branch pacing in a patient with amyloid light-chain cardiac amyloidosis.Case summary: A 66-year-old male patient with amyloid light-chain cardiac amyloidosis presented with syncope for 1 month. Holter monitoring revealed intermittent third-degree atrioventricular block. Left bundle branch pacing was performed successfully. During the 1-year follow-up, it was observed that the left bundle branch capture threshold remained stable without any pacemaker-related complications or left ventricle systolic dysfunction, and there was no recurrence of syncope.Conclusion: Left bundle branch pacing appears to be a safe and feasible option for patients with amyloid light-chain cardiac amyloidosis experiencing atrioventricular block.

17 October 2011 in Congestive Heart Failure
Verified
Journal Article
Open access
PDF file
ZCZhongwei Cheng
Zhongwei Cheng
KZKongbo Zhu
Kongbo Zhu
TCTaibo Chen
Taibo Chen
PGPeng Gao
Peng Gao
KCKang'an Cheng
Kang'an Cheng
QFQuan Fang
Quan Fang
Most Chinese cardiologists are challenged by the high mortality rate of heart failure (HF) in patients with reduced ejection fraction in China. This study was designed as a single‐center, retrospective study. All consecutive HF patients with left ventricular ejection fraction (LVEF) ≤45% from January 1, 2007, to December 31, 2009, were enrolled. The primary outcome was all‐cause mortality. The secondary outcome was all‐cause mortality or the first cardiovascular readmission event. A total of 187 patients comprised the study population, classified into two groups: LVEF ≤35% (n=83) and LVEF 36% to 45% (n=104). The median follow‐up was 18 months (2–41 months). All‐cause mortality was 27% among patients with LVEF ≤35%, as compared with 14% among those with LVEF 36% to 45% ( P=.025). All‐cause mortality or first cardiovascular readmission rates were 53% and 32% among patients with LVEF ≤35% and 36% to 45% (P=.003), respectively. The predictors of all‐cause mortality were advanced age and New York Heart Association functional class, chronic kidney disease, oral β‐blockers, and statins at discharge. The prognosis of chronic HF patients with LVEF ≤45% was poor in China, especially for patients with LVEF ≤35%. Cardiologists should provide further efforts to improve the prognosis of HF in Chinese patients. ©2011 Wiley Periodicals, Inc.